Evaluation of the long-term effectiveness of rehabilitation programs in patients with post-COVID syndrome

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Subjects and methods. In August 2021 to March 2022, a prospective cohort study involving 113 patients with PCS. According to the rehabilitation method, the patients were divided into 4 study group (n=25) that used a rehabilitation program developed in terms of the respiratory rehabilitation principles; comparison group 2 (n=25), the patients of which refused to undergo rehabilitation; comparison group 2 (n=29) that had undergone methods of oriental medicine; Comparison group 3 (n=34) that had balneotherapy and physiotherapy. The groups were matched for sex, age, and rehabilitation routing scale. During the follow-up period, the hospitalization rates were recorded in the groups due to an exacerbation of PCS, death, or disability, as well as the need for for other types of care.

Results. The patients of comparison groups 1-3 are more likely to seek treatment for the symptoms of PCS (χ2=6.635; p=0.001; χ2=13.463; p=0,001; χ2=10.949, p=0.001, respectively), and also more often hospitalized (χ2=5.357; p=0.021; χ2=0.125; p=0.724; χ2=0.856; p=0.355, respectively) than those of the study group. The relative risk (RR) of hospitalizations in the study group compared to the comparison groups was 0.143 (confidence interval [CI] – 0.1–1.0), 0.580 (CI – 0.1–6.0), 0.340 (CI – 0.1–2,9), respectively. The reduction in the RR of hospitalizations in the study group compared to the comparison groups was 85.7; 42.0, and 66.0%, respectively.

Conclusion. The program developed in terms of the respiratory rehabilitation principles showed the highest effectiveness in patients with PCS after 6 months of application.

Full Text

Restricted Access

About the authors

I. A. Grishechkina

National Medical Research Center for Rehabilitation and Balneology, Ministry of Health of Russia

Author for correspondence.
Email: GrishechkinaIA@nmicrk.ru

Candidate of Medical Sciences

Russian Federation, Moscow

References

  1. WHO: Clinical case definition post-COVID-19 by Delphi consensus. 06.10.2021. URL: https://apps.who.int/iris/bitstream/handle/10665/345824/WHO-2019-nCoV-Post-COVID-19-condition-Clinical-case-definition-2021.1-rus.pdf
  2. Barker-Davies R.M., O'Sullivan O., Senaratne K.P.P. et al. The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med. 2020; 54 (16): 949–59. doi: 10.1136/bjsports-2020-102596
  3. Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. 2021; 53 (10): 737–54. doi: 10.1080/23744235.2021.1924397
  4. Halpin S.J., McIvor C., Whyatt, G. et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol. 2021; 93 (2): 1013–22. doi: 10.1002/jmv.26368
  5. Hodgson C.L., Higgins A.M., Bailey M.J. et al. & The COVID-Recovery Study Investigators and the ANZICS Clinical Trials Group. The impact of COVID-19 critical illness on new disability, functional outcomes and return to work at 6 months: a prospective cohort study. Crit Care. 2021; 25 (1): 382. doi: 10.1186/s13054-021-03794-0
  6. Das S. Microcirculatory changes and thrombotic complications in COVID-19. Br J Community Nurs. 2021; 26 (10): 474–80. doi: 10.12968/bjcn.2021.26.10.474
  7. Pandolfi S., Chirumbolo S. Home therapy of COVID-19 at the earliest may greatly prevent hospitalization. Basik Clin Pharmacol Toxicol. 2021; 129 (6): 395–6. doi: 10.1111/bcpt.13650
  8. Hohberger B., Mardin C.Y. OCT-Angiografie als interdisziplinäres Diagnostikum für Systemerkrankungen. Klin Monbl Augenheilkd. 2021; 238 (12): 1294–8. doi: 10.1055/a-1654-0504
  9. Lobanov A.A., Grishechkina I.A., Andronov S.V. et al. Can aquatic exercises contribute to the improvement of the gait stereotype function in patients with Long COVID outcomes? Eur J Transl Myol. 2022; 32 (3): 10698. doi: 10.4081/ejtm.2022.10698
  10. Мещерякова Н.Н., Белевский А.С., Кулешов А.В. Методические рекомендации. Проведение легочной реабилитации у пациентов с новой коронавирусной инфекцией (COVID-19) внебольничной двухсторонней пневмонией. М., 2020; 22 с. [Meshcheryakova N.N., Belevsky A.S., Kuleshov A.V. Methodical guidelines. Carrying out pulmonary rehabilitation in patients with new coronavirus infection (COVID-19) outpatient bilateral pneumonia. Moscow, 2020; 22 p. (in Russ.)]. URL https://www.spulmo.ru/upload/metodichka_po_reabilitacii_covid.pdf
  11. Лобанов А.А., Гришечкина И.А., Фесюн А.Д. и др. Исследование эффективности и безопасности реабилитационной программы пациентов с постковидным синдромом с применением акватренировок. Вестник восстановительной медицины. 2022; 21 (3): 45–57 [Lobanov A.A., Grishechkina I.A., Fesyun A.D. et al. Investigation of the Effectiveness and Safety of a Rehabilitation Program for Patients with Long Covid Using Aquatic Training. Bulletin of Rehabilitation Medicine. 2022; 21 (3): 45–57 (in Russ.)]. doi: 10.38025/2078-1962-2022-21-3-45-57
  12. Carfi A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324 (6): 603–5. doi: 10.1001/jama.2020.12603
  13. Rutsch M., Frommhold J., Buhr-Schinner H. et al. Study protocol medical rehabilitation after COVID-19 disease: an observational study with a comparison group with obstructive airway disease / Re_Co. BMC Health Serv Res. 2021; 21 (1): 373. doi: 10.1186/s12913-021-06378-4
  14. McAlister F.A., MMath Y.D., Chu A. et al. The risk of death or unplanned readmission after discharge from a COVID-19 hospitalization in Alberta and Ontario. CMAJ. 2022; 194 (19): E666–E673. doi: 10.1503/cmaj.220272
  15. Дедов Д.В., Марченко С.Д. Витамины, железо, цинк, селен, селенсодержащие лекарственные препараты в комплексной профилактике осложнений и лечении больных COVID-19. Фармация. 2022; 71 (1): 5–9 [Dedov D.V., Marchenko S.D. Vitamins, iron, zinc, selenium and selenium-containing medicines in the comprehensive prevention of complications and treatment of COVID-19 patients. Farmaciya. 2022; 71 (1): 5–9 (in Russ.)]. doi: 10.29296/25419218-2022-01-01

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies